The Effects of Prazosin on Dopamine in Healthy Humans: A PET Pilot Study
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Pfizer
Related studies linked through entity extraction aliases.
Ertugliflozin vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
- Status
- COMPLETED
- Phase
- PHASE3
Understanding Pneumococcal Carriage and Disease
- Status
- COMPLETED
- Phase
- N/A
Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
- Status
- COMPLETED
- Phase
- PHASE3
Phase 1 Study to Characterize the Safety and Pharmacokinetics of Single Intravenous Dose of Lorazepam in Healthy Japanese Adult Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Linezolid Instead of Ethambutol in Treatment of Drug-susceptible Tuberculosis
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema
- Status
- TERMINATED
- Phase
- PHASE2
A Single Dose Study Of PF-06678552 In Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Intravenous and Multiple Subcutaneous and Intravenous Doses of PF-06480605 in Healthy Subjects.
- Status
- COMPLETED
- Phase
- PHASE1
Cardiovascular Outcomes Following Ertugliflozin Treatment in Type 2 Diabetes Mellitus Participants With Vascular Disease, The VERTIS CV Study (MK-8835-004)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
- Status
- COMPLETED
- Phase
- PHASE3
A Phase I Trial to Investigate the Safety and Tolerability of PF-06649751
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1 Study To Evaluate Tolerability, Safety, And Pharmacokinetics Of Topical PF-06263276 In Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Safety, Tolerability, Pharmacokinetics, And Effects On Histamine-Induced Wheal Of PF-05180999 In Healthy Adults
- Status
- TERMINATED
- Phase
- PHASE1
A Study Of The Safety, Tolerability, And Pharmacokinetics Of Multiple Doses Of PF-05180999 In Healthy Adults
- Status
- WITHDRAWN
- Phase
- PHASE1
Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab
- Status
- COMPLETED
- Phase
- N/A
LGX818 for Patients With BRAFV600 Mutated Tumors
- Status
- TERMINATED
- Phase
- PHASE2